Gall bladder sludge and stones in multitransfused Egyptian thalassaemic patients;Boues et calculs biliaires chez des patients thalassémiques égyptiens polytranstusés

Eastern Mediterranean Health Journal

Volumn 7, Issue 4-5, 2001, Pages 635-641

  El Nawawy, A ^a   Kassem, A S ^a   Eissa, M ^a   Abdel Fattah, M ^a   Safwat, M ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ECHOGRAPHY; EGYPT; FEMALE; GALLBLADDER DISEASE; GALLBLADDER SLUDGE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETICULOCYTE COUNT; RISK FACTOR; THALASSEMIA; YOUNG ADULT; ADOLESCENT; AGE DISTRIBUTION; BETA THALASSEMIA; BILE; BLOOD; BLOOD TRANSFUSION; CASE CONTROL STUDY; CHILD; GALLSTONE; HOSPITAL; INCIDENCE; LEUKOCYTE COUNT; STATISTICAL MODEL; STATISTICS; UNIVERSITY HOSPITAL;

BILIRUBIN; HEMOGLOBIN;

ADOLESCENT; AGE DISTRIBUTION; BETA-THALASSEMIA; BILE; BILIRUBIN; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; CHILD; EGYPT; FEMALE; GALLSTONES; HEMOGLOBINS; HOSPITALS, PEDIATRIC; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; PREVALENCE; RETICULOCYTE COUNT; RISK FACTORS;

EID: 4944219604     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Honig GR. Hemoglobin disorders. In: Behrman RE, Kliegman RM, Jensen HB, eds. Nelson textbook of pediatrics, 16th ed. Philadelphia, WB Saunders Company, 2000:1484-7.
2. Clegg JB. Thalassemia and malaria Medicine digest. 1990. 16:13-7.
3. Giardini C. Treatment of beta-thalas-semia. Current opinion in hematology, 1997, 4(2):79-87
4. Borgna-Pignatti C et al. Survival and disease complications in thalassemia major. Annala of the New York Academy of Science, 1998, 850:227-31.
5. Frempong KO, Schwatz E. Clinical features ot tnaiassemia. Pediatric clinics of North America, 1980, 27:403-19.
6. Holcomb Jr GW, Holcomb 3rd GW. Cholelithiasis in infants, children, and adolescents. Pediatrics in review, 1990, 11 (9):268-74.
7. Segel GB. Definitions and classifications of hemolytic anemias. In: Behrman RE, Kliegman RM, Jensen HB, eds. Nelson textbook of pediatrics, 16th ed. Philadelphia, WB Saunders Company, 2000:1472-5.
8. Paumgartner G, Sauerbruch T. Gallstones: pathogenesis. Lancet, 1991, 338:1117-21.
9. Senaati S et al. Gallbladder pathology in pediatric beta-thalassaemic patients. A prospective ultrasonographic study. Pediatric radiology, 1993, 23(5):357-9.
10. Chawla Y et al. Multitransfused children with thalassemia major do not have gallstones. Tropical gastroenterology, 1997, 18(3): 107-8.
11. Ooldfarb A et al. High inoidonoo of cholelithiasis in older patients with homozygous beta-thalassemia. Acta haematnlnctica. 1990. 83(3): 120-2.
12. Sarnaik S et al. Incidence of cholelithiasis in sickle-cell anemia using the ultra-sonic gray-scale technique. Journal of pediatrics, 1980, 96:1005-8.
13. Oracle WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. New England journal of medicine, 1982, 307:798-800.
14. Walker TM, Serjeant GR. Biliary sludge in sickle-cell disease. Journal of pediatrics, 1996, 129(3):443-5.
15. Ostrow JD, Celic L. Bilirubin chemistry, ionization and solubilization by bile salts. Hepatology, 1984, 4:38S-45S.
16. Risdon RA, Barry M, Flynn DM. Transfu-sional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassemia. Journal of pathology, 1975, 116:83-95.
17. lancu TL, Neustein HB. Ferritin in human liver cells of homozygous beta-thalaesemia: ultrastructural observations. British journal of haematology, 1977, 37:527-35.
18. Masera G et al. Role of chronic hepatitis in development of thalassaemic liver disease. Archives of disease in childhood, 1976, 51:880-5.
19. De Virgiliis S, Cornacchia G et al. Chronic liver disease in transfusion-de-pendent thalassaemia: liver iron quantitation and distribution. Acta haematologica, 1981, 65:32-9.
20. Tam SC et al. Growth hormone therapy transiently increases apolipoprotein (a) in short beta-thalassaemia major children with normal growth hormone reserve. Atherosclerosis, 1997, 128(2): 175-82.